Aspen Aerogels (NYSE:ASPN – Free Report) had its price objective cut by Barclays from $27.00 to $25.00 in a report released on Tuesday morning,Benzinga reports. They currently have an overweight rating on the construction company’s stock.
Other research analysts have also issued research reports about the company. Roth Mkm dropped their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. TD Cowen boosted their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Thursday, October 31st. HC Wainwright reissued a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Finally, Benchmark restated a “buy” rating and issued a $14.00 price target on shares of Aspen Aerogels in a report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $28.70.
Get Our Latest Research Report on Aspen Aerogels
Aspen Aerogels Price Performance
Insider Buying and Selling at Aspen Aerogels
In related news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This trade represents a 11.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares of the company’s stock, valued at $626,610.60. This represents a 60.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the company. Barclays PLC lifted its position in Aspen Aerogels by 333.8% during the third quarter. Barclays PLC now owns 92,302 shares of the construction company’s stock valued at $2,557,000 after acquiring an additional 71,024 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new position in shares of Aspen Aerogels during the third quarter worth $420,000. Kovitz Investment Group Partners LLC purchased a new stake in shares of Aspen Aerogels during the 3rd quarter valued at $263,000. Wellington Management Group LLP acquired a new stake in shares of Aspen Aerogels in the 3rd quarter worth $4,171,000. Finally, Sora Investors LLC purchased a new position in Aspen Aerogels during the 3rd quarter worth $3,461,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- What is the Hang Seng index?
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Industrial Products Stocks Investing
- Top-Performing Non-Leveraged ETFs This Year
- Investing in Commodities: What Are They? How to Invest in Them
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.